Follow Us

header ads
header ads

In-Vitro Fertilization Market Value is Projected to Reach $ 33 Bn by 2030

 The global in-vitro fertilization market size is expected to reach around US$ 33 billion by 2030 from US$ 15.72 billion in 2021 and is expected to grow at an impressive double-digit rate of 8.6% from 2021 to 2030.

In-Vitro Fertilization Market Size 2020 to 2030

The study includes drivers and restraints of this market. The study provides an analysis of the global in-vitro fertilization market for the period 2017-2030, wherein 2021 to 2030 is the forecast period and 2020 is considered as the base year.

The global in-vitro fertilization market is primarily driven by various factors such as rising male infertility, increasing in the median age of first time mothers, increasing obesity, declining fertility rates, and growing consumption of alcohol. Moreover, the rising awareness regarding the infertility coupled with the availability of advanced treatment options is fueling the demand for the in-vitro fertilization. The rising median age of the first time mothers is a significant growth driver.

We customize your report according to your research need. REQUEST CUSTOMIZED COPY OF REPORT (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/customization/1501

Why should you invest in this report?

If you are aiming to enter the global in-vitro fertilization market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for in-vitro fertilization are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030, so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Some of the prominent players in the global in-vitro fertilization market include:

  • AmbroiseParé Group
  • Amedes MVZ Cologne GmbH
  • AMP Center St Roch
  • AVA Clinic Scanfert
  • Bangkok IVF center
  • Betamedics
  • Biofertility Center
  • Bloom Fertility and Healthcare
  • Bloom Fertility Center
  • Bourn Hall Fertility Center

Market Segmentation:

By Product Type

  • Fresh Donor
  • Fresh Non-Donor
  • Frozen Donor
  • Frozen Non-Donor

By End User

  • Fertility Clinics
  • Surgical Centers
  • Hospitals
  • Research Institutes

By Instrument

  • Culture Media
  • Disposable Devices
  • Capital Equipment

Regional Analysis:

The geographical analysis of the global in-vitro fertilization market has been done for North America, Europe, Asia-Pacific, and the Rest of the World.

The North American Market is again segmented into the US, Canada, and Mexico. Coming to the European Market, it can be segmented further into the UK, Germany, France, Italy, Spain, and the rest. Coming to the Asia-Pacific, the global in-vitro fertilization Market is segmented into China, India, Japan, and Rest of Asia Pacific. Among others, the market is segmented into the Middle East and Africa, (GCC, North Africa, South Africa and Rest of the Middle East & Africa).

Key Questions Answered by the Report:

  • What will be the size of the global in-vitro fertilization market in 2030?
  • What is the expected CAGR for the in-vitro fertilization market between 2021 and 2030?
  • Which are the top players active in this global market?
  • What are the key drivers of this global market?
  • How will the market situation change in the coming years?
  • Which region held the highest market share in this global market?
  • What are the common business tactics adopted by players?
  • What is the growth outlook of the global in-vitro fertilization market?

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on In-Vitro Fertilization Market 

5.1. COVID-19 Landscape: In-Vitro Fertilization Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global In-Vitro Fertilization Market, By Product

8.1. In-Vitro Fertilization Market, by Product Type, 2021-2030

8.1.1. Fresh Donor

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Fresh Non-Donor

8.1.2.1. Market Revenue and Forecast (2019-2030)

8.1.3. Frozen Donor

8.1.3.1. Market Revenue and Forecast (2019-2030)

8.1.4. Frozen Non-Donor

8.1.4.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global In-Vitro Fertilization Market, By End User

9.1. In-Vitro Fertilization Market, by End User, 2021-2030

9.1.1. Fertility Clinics

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Surgical Centers

9.1.2.1. Market Revenue and Forecast (2019-2030)

9.1.3. Hospitals

9.1.3.1. Market Revenue and Forecast (2019-2030)

9.1.4. Research Institutes

9.1.4.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global In-Vitro Fertilization Market, By Instrument 

10.1. In-Vitro Fertilization Market, by Instrument, 2021-2030

10.1.1. Culture Media

10.1.1.1. Market Revenue and Forecast (2019-2030)

10.1.2. Disposable Devices

10.1.2.1. Market Revenue and Forecast (2019-2030)

10.1.3. Capital Equipment

10.1.3.1. Market Revenue and Forecast (2019-2030)

Chapter 11. Global In-Vitro Fertilization Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2019-2030)

11.1.2. Market Revenue and Forecast, by End User (2019-2030)

11.1.3. Market Revenue and Forecast, by Instrument (2019-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product (2019-2030)

11.1.4.2. Market Revenue and Forecast, by End User (2019-2030)

11.1.4.3. Market Revenue and Forecast, by Instrument (2019-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.1.5.2. Market Revenue and Forecast, by End User (2019-2030)

11.1.5.3. Market Revenue and Forecast, by Instrument (2019-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2019-2030)

11.2.2. Market Revenue and Forecast, by End User (2019-2030)

11.2.3. Market Revenue and Forecast, by Instrument (2019-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product (2019-2030)

11.2.4.2. Market Revenue and Forecast, by End User (2019-2030)

11.2.4.3. Market Revenue and Forecast, by Instrument (2019-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.2.5.2. Market Revenue and Forecast, by End User (2019-2030)

11.2.5.3. Market Revenue and Forecast, by Instrument (2019-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product (2019-2030)

11.2.6.2. Market Revenue and Forecast, by End User (2019-2030)

11.2.6.3. Market Revenue and Forecast, by Instrument (2019-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product (2019-2030)

11.2.7.2. Market Revenue and Forecast, by End User (2019-2030)

11.2.7.3. Market Revenue and Forecast, by Instrument (2019-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2019-2030)

11.3.2. Market Revenue and Forecast, by End User (2019-2030)

11.3.3. Market Revenue and Forecast, by Instrument (2019-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product (2019-2030)

11.3.4.2. Market Revenue and Forecast, by End User (2019-2030)

11.3.4.3. Market Revenue and Forecast, by Instrument (2019-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.3.5.2. Market Revenue and Forecast, by End User (2019-2030)

11.3.5.3. Market Revenue and Forecast, by Instrument (2019-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product (2019-2030)

11.3.6.2. Market Revenue and Forecast, by End User (2019-2030)

11.3.6.3. Market Revenue and Forecast, by Instrument (2019-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product (2019-2030)

11.3.7.2. Market Revenue and Forecast, by End User (2019-2030)

11.3.7.3. Market Revenue and Forecast, by Instrument (2019-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2019-2030)

11.4.2. Market Revenue and Forecast, by End User (2019-2030)

11.4.3. Market Revenue and Forecast, by Instrument (2019-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product (2019-2030)

11.4.4.2. Market Revenue and Forecast, by End User (2019-2030)

11.4.4.3. Market Revenue and Forecast, by Instrument (2019-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.4.5.2. Market Revenue and Forecast, by End User (2019-2030)

11.4.5.3. Market Revenue and Forecast, by Instrument (2019-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product (2019-2030)

11.4.6.2. Market Revenue and Forecast, by End User (2019-2030)

11.4.6.3. Market Revenue and Forecast, by Instrument (2019-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product (2019-2030)

11.4.7.2. Market Revenue and Forecast, by End User (2019-2030)

11.4.7.3. Market Revenue and Forecast, by Instrument (2019-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.5.2. Market Revenue and Forecast, by End User (2019-2030)

11.5.3. Market Revenue and Forecast, by Instrument (2019-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product (2019-2030)

11.5.4.2. Market Revenue and Forecast, by End User (2019-2030)

11.5.4.3. Market Revenue and Forecast, by Instrument (2019-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.5.5.2. Market Revenue and Forecast, by End User (2019-2030)

11.5.5.3. Market Revenue and Forecast, by Instrument (2019-2030)

Chapter 12. Company Profiles

12.1. AmbroiseParé Group

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Amedes MVZ Cologne GmbH

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. AMP Center St Roch

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. AVA Clinic Scanfert

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Bangkok IVF Center

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Bangkok IVF center

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Betamedics

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Biofertility Center

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Bloom Fertility and Healthcare

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Bloom Fertility Center

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

12.11. Bourn Hall Fertility Center

12.11.1. Company Overview

12.11.2. Product Offerings

12.11.3. Financial Performance

12.11.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1501

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://precedenceresearchnews.wordpress.com

Follow us on LinkedIn | Twitter | Facebook

Post a Comment

0 Comments